Assertio Holdings, Inc. (ASRT) Dividend History

Assertio Holdings, Inc. is a pharmaceutical company focused on developing and commercializing innovative therapies for neurological and other specialized conditions. It provides products that address unmet medical needs, often through drug delivery mechanisms aimed at improving patient outcomes. The company operates in the United States and offers a portfolio of medications targeting areas such as pain management, neurology, and inflammation.

100 S. Saunders Road, Lake Forest, IL, 60045
Phone: (224) 419-7106
Website: https://www.assertiotx.com

Dividend History

Assertio Holdings, Inc. currently does not pay dividends

Company News

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

A class action lawsuit has been filed against Assertio Holdings, Inc. (NASDAQ: ASRT) alleging that the company and its executives made false and misleading statements in the registration statement for its merger with Spectrum Pharmaceuticals, Inc. The lawsuit claims the statements overstated the strength of Indocin, downplayed the risk of generic competition, and misrepresented the benefits of the merger.

GlobeNewswire Inc.
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Assertio Holdings, Inc. announced that it has granted 62,500 restricted stock units and 275,000 stock options to its newly-hired Senior Vice President, Chief Commercial Officer, Mary Pietryga, as an inducement to her employment.

GlobeNewswire Inc.
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

Beam Therapeutics, a biotechnology company developing precision genetic medicines, has appointed Sravan K. Emany as its new Chief Financial Officer. Emany brings extensive experience in the life sciences industry and will help guide Beam's growth and capital allocation strategy.

GlobeNewswire Inc.

Featured Companies: BEAM IART IRWD
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., June 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that effective May 31, 2024, the Compensation Committee of the Company’s Board of Directors granted the Company’s new Chief Executive Officer, Brendan P. O’Grady, 500,000 restricted stock units (“RSUs”) and 1,800,000 stock options (“options”).

GlobeNewswire Inc.
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will present at the Sidoti Small Cap Conference, which will take place virtually on June 12, 2024.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 19:50:41 UTC